Partial regression of primary cutaneous melanoma: Is there an association with sub-clinical sentinel lymph node metastasis?

American Journal of Dermatopathology

Volumn 25, Issue 5, 2003, Pages 371-376

  Fontaine, Dan ^a   Parkhill, Winston ^a   Greer, Wenda ^a   Walsh, Noreen ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Prognostic factor; Regression of melanoma; Sentinel lymph node metastasis

Indexed keywords

ADULT; AGED; ARTICLE; BRESLOW THICKNESS; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION COEFFICIENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; PRIORITY JOURNAL; PROGNOSIS; SCAR; SENTINEL LYMPH NODE; TUMOR REGRESSION; TUMOR VOLUME; ULCER;

ADULT; AGED; AGED, 80 AND OVER; DNA, NEOPLASM; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 0141565487     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200310000-00002     Document Type: Article

References (25)

1. Gromet M, Epstein WL, Blois MS. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer. 1978;48:2282-2292.
2. Paladugu RR, Yonemoto RH. Biologic behavior of thin malignant melanomas with regressive changes. Arch Surg. 1983;118:41-44.
3. Naruns PL, Nizze JA, Cochran AJ, et al. Recurrence potential of thin primary melanomas. Cancer. 1986;57:545-548.
4. Ronan SG, Eng AM, Briele HA, et al. Thin malignant melanomas with regression and metastases. Arch Dermatol. 1987;123:1326-1330.
5. Slingluff CL, Vollmer RT, Reintgen DS, et al. Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg. 1988;208:150-161.
6. Sondergaard K, Hou-Jensen K. Partial regression in thin primary cutaneous malignant melanomas clinical stage 1. Virchows Arch. 1985;408:241-247.
7. Blessing K, McLaren KM. Histological regression in primary cutaneous melanoma: recognition, prevalence and significance. Histopathology. 1992;20:315-322.
8. Clark WH Jr, Eder DE, Guerry D, et al. Model predicting survival in stage 1 melanoma based on tumour progression. J Natl Cancer Inst. 1989;81:1893-1904.
9. Blessing K, McLaren KM, McLean A, et al. Thin malignant melanoma (<1. 5 mmp) with metastases and death. Histological study and survival analysis. Histopathology. 1990;17:389-395.
10. McGovern VJ. Spontaneous regression of melanoma. Pathology (Phila). 1975;7:91-99.
11. McGovern VJ, Shaw HM, Milton GW, et al. Prognostic significance of the histological features of malignant melanoma. Histopathology. 1979;3:385-393.
12. McGovern VJ, Shaw HM, Milton GW. Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology. 1983;7:673-679.
13. Kelly JW, Sagebiel RW, Blois MS. Regression in malignant melanoma: a histologic feature without independent prognostic significance. Cancer. 1985;56:2287-2291.
14. Cooper PH, Wanebo HJ, Hagar RW. Regression in thin malignant melanoma. Arch Dermatol. 1985;121:1127-1131.
15. Briggs JC, Ibrahim HBN, Hastings AG, et al. Experience of thin cutaneous melanomas (<0.76 mm and >0.85 mm thick) in a large plastic surgery unit: a five to 17 year follow-up. Br J Plast Surg. 1984;37:501-506.
16. Shaw HM, McCarthy WH, McCarthy SW, et al. Thin malignant melanomas and recurrence potential. Arch Surg. 1987;122:1147-1150.
17. Trau H, Rigel DS, Harris MN, et al. Metastases of thin melanomas. Cancer. 1983;51:553-556.
18. Wanebo HJ, Cooper PH, Hagar RW. Thin (≤1 mm) melanomas of the extremities are biologically favourable lesions not influenced by regression. Ann Surg. 1985;201:499-504.
19. Balch CM, Soong S, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol. 2001;19:3622-3634.
20. Shaw HM, McCarthy SW, McCarthy WH, et al. Thin Regressing Malignant Melanoma: significance of regional lymph node metastasis. Histopathology. 1989;15:257-265.
21. Fontaine D, Parkhill W, Greer W, et al. Nevus cells in lymph nodes: An association with congenital cutaneous nevi. Am J Dermatopathol. 2002;24:1-5.
22. Busam KJ, Antonescu CR, Ashfaq AM, et al. Histologic classification of tumour-infiltrating lymphocytes in primary cutaneous malignant melanoma. Am J Clin Pathol. 2001;115:856-860.
23. Barnhill RL. Prognostic factors in cutaneous melanoma. In: Barnhill RL, ed. Pathology of Melanocytic Nevi and Malignant Melanoma. Boston, MA: Butteworth - Heinemann; 1995:269-284.
24. Weissman A, Harris MN, Roses DF, et al. Prediction of lymph node metastases from the histologic features of primary cutaneous malignant melanomas. Am J Dermatopathol. 1984;6(Suppl 1):35-41.
25. Mraz-Gemhard S, Sagebiel RW, Kashani-Sabet M, et al. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol. 1998;134:983-987.